BREAKING: CDC advisory group votes to recommend Pfizer’s Covid vaccine booster for at-risk populations.
Millions of Americans ages 65 and over and older people with underlying medical conditions will be eligible for a third dose.
All people ages 65 and up and those in long-term care facilities who were initially vaccinated with the Pfizer vaccine should receive a booster dose. People ages 50 to 64 with underlying medical conditions should also get a booster dose. The additional shots would be administered at least six months after people complete their initial vaccination series.
The committee members expressed significant concern about a booster shot for younger people due to lack of evidence about safety and waning protection against severe disease. The CDC noted that the recommendation of a booster dose would not change the definition of who is considered fully vaccinated. That is, people are considered fully vaccinated two weeks after getting their second dose of either the Pfizer or the Moderna vaccines or their first dose of the Johnson & Johnson vaccine.Thursday’s recommendation only applies to the Pfizer vaccine, and people who were initially vaccinated with the Pfizer vaccine.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And OlderPfizer said a third shot would restore the effectiveness of its COVID-19 vaccine to about 95%.
Read more »
CDC advisory panel votes to recommend Pfizer boosters for people 65 and olderBREAKING: The CDC's independent advisory panel has unanimously voted to recommend booster doses of Pfizer's COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months after their second dose.
Read more »
CDC panel recommends Pfizer boosters for high-risk individuals, people 65 and upA key panel at the Centers for Disease Control and Prevention on Thursday recommended the Pfizer-BioNTech coronavirus booster shots for people 65 years old and older, as well as those at high risk of severe COVID-19. Why it matters: The approval is the near-final step in making the booster shots available to tens of millions of Americans, and comes a day after the FDA approved Pfizer boosters for the two groups. CDC director Rochelle Walensky is expected to accept the recommendation.Stay on top
Read more »
COVID-19 live updates: CDC advisory panel expected to vote on Pfizer booster within hoursThe CDC’s independent advisory panel is set to vote this afternoon on which Americans are eligible now for a Pfizer booster.
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »